Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Deloitte
Novartis
Merck
US Department of Justice
Boehringer Ingelheim
Fuji
Citi
UBS
Medtronic

Generated: February 18, 2018

DrugPatentWatch Database Preview

Famotidine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for famotidine and what is the scope of famotidine patent protection?

Famotidine
is the generic ingredient in eleven branded drugs marketed by Hi-tech Pharma Co, Lupin Ltd, Navinta Llc, Novel Labs Inc, Salix Pharms, Apotex Inc, Apothecon, Athenex Inc, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, West-ward Pharms Int, Abbvie, Baxter Hlthcare, Merck, Merck Sharp Dohme, Perrigo, J And J Consumer Inc, Ucb Inc, Actavis Elizabeth, Alembic Pharms Ltd, Apotex, Aurobindo Pharma Ltd, Carlsbad, Dr Reddys Labs Ltd, Ivax Sub Teva Pharms, Mylan, Mylan Pharms Inc, Perrigo R And D, Sandoz, Sun Pharm Inds Ltd, Sun Pharm Industries, Teva, Watson Labs, Wockhardt, Wockhardt Ltd, Valeant Pharms North, and Horizon Pharma, and is included in sixty-nine NDAs. There are nine patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Famotidine has sixteen patent family members in nine countries.

There are eighteen drug master file entries for famotidine. One hundred and eighteen suppliers are listed for this compound. There are five tentative approvals for this compound.
Pharmacology for famotidine
Medical Subject Heading (MeSH) Categories for famotidine
Tentative approvals for FAMOTIDINE
Applicant Application No. Strength Dosage Form
➤ Try a Free Trial➤ Try a Free Trial10MG/MLInjectable; Injection
➤ Try a Free Trial➤ Try a Free Trial10MG/MLInjectable; Injection
➤ Try a Free Trial➤ Try a Free Trial10MG/MLInjectable; Injection

US Patents and Regulatory Information for famotidine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz FAMOTIDINE famotidine TABLET;ORAL 075302-002 Apr 16, 2001 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020325-002 Sep 23, 2003 OTC Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apotex FAMOTIDINE famotidine TABLET;ORAL 075611-001 Jul 23, 2001 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ivax Sub Teva Pharms FAMOTIDINE famotidine TABLET;ORAL 075511-001 Apr 16, 2001 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ivax Sub Teva Pharms FAMOTIDINE famotidine TABLET;ORAL 075511-002 Apr 16, 2001 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs FAMOTIDINE famotidine TABLET;ORAL 075404-001 Nov 28, 2001 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Horizon Pharma DUEXIS famotidine; ibuprofen TABLET;ORAL 022519-001 Apr 23, 2011 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharm Inds Ltd FAMOTIDINE famotidine TABLET;ORAL 090283-002 Nov 17, 2009 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER famotidine INJECTABLE;INJECTION 075591-001 May 10, 2001 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apotex Inc FAMOTIDINE PRESERVATIVE FREE famotidine INJECTABLE;INJECTION 076324-001 Nov 27, 2002 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for famotidine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER famotidine INJECTABLE;INJECTION 020249-001 Feb 18, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020325-001 Apr 28, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Merck PEPCID RPD famotidine TABLET, ORALLY DISINTEGRATING;ORAL 020752-001 May 28, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Merck PEPCID RPD famotidine TABLET, ORALLY DISINTEGRATING;ORAL 020752-001 May 28, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms North PEPCID famotidine TABLET;ORAL 019462-001 Oct 15, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms North PEPCID famotidine TABLET;ORAL 019462-002 Oct 15, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Merck PEPCID RPD famotidine TABLET, ORALLY DISINTEGRATING;ORAL 020752-001 May 28, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Salix Pharms PEPCID famotidine FOR SUSPENSION;ORAL 019527-001 Feb 2, 1987 ➤ Try a Free Trial ➤ Try a Free Trial
Merck PEPCID RPD famotidine TABLET, ORALLY DISINTEGRATING;ORAL 020752-002 May 28, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020325-001 Apr 28, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for famotidine

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Moodys
Cantor Fitzgerald
Federal Trade Commission
Harvard Business School
Deloitte
UBS
Cerilliant
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot